WASHINGTON (AP) -- The maker of a drug for Lou Gehrig's disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition.
Related Keywords
China , Washington , United States , Cambridge , Cambridgeshire , United Kingdom , Canada , Chinese , Lou Gehrig , Drug Administration , Amylyx Pharmaceuticals , Massachusetts Based Amylyx ,
comparemela.com © 2020. All Rights Reserved.